AIDS Vaccine Efficacy May Not Transfer To U.S. Population, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The U.S. Army is conducting a Phase III study in Thailand of a product that combines Sanofi-Aventis and VaxGen vaccines, briefing materials for Vaccines & Related Biological Products Advisory Committee’s Sept. 23 meeting state. However, FDA considers the trial to be a “proof of concept” study.